The antitumor potential of Interleukin-27 in prostate cancer.
about
Potential clinical application of interleukin-27 as an antitumor agent.Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer.Decreased IL-27 Negatively Correlated with Th17 Cells in Non-Small-Cell Lung Cancer Patients.Immune Regulation of Interleukin-27 in Malignant Pleural EffusionIL-27 induces the expression of IDO and PD-L1 in human cancer cells.Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.Dual Roles of IL-27 in Cancer Biology and Immunotherapy.Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells.IL-27 regulates the adherence, proliferation, and migration of MSCs and enhances their regulatory effects on Th1 and Th2 subset generations.IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review.The cross talk between cervical carcinoma cells and vascular endothelial cells mediated by IL-27 restrains angiogenesis.Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation.
P2860
Q34483131-EB27E038-F8AA-44ED-A7E8-CDF4972F6D8DQ35551845-9D81FC51-2607-4604-85B6-DE78FD579ACDQ35563504-DE34241A-DDEF-435C-B98F-A2CBE0810BEBQ36477134-187EE42B-A03B-4D03-834E-52942C7D2414Q36685395-912F8534-695A-45AF-BB6E-C710895333D8Q37687254-8563ECD3-C867-4EA2-A855-AD2001937412Q39158943-8683074A-EC97-487A-AA30-F8F3F603A8C5Q41078957-E7A56A3C-8651-4E3D-8889-814BB796474EQ41261079-060719FE-58FA-48DC-8687-A28858BDE389Q42375251-A07D93A6-B76F-48DF-9A13-C32E5704739DQ47105622-ED6518FB-283E-418E-BA23-F6163BF99E21Q48139778-EB3A0BD6-FA0C-4650-AA0F-E488146F7AA3Q51279715-30F13BE8-1089-4679-AC8E-9C61CF8A5293Q53082211-75EB1F0F-E20E-4295-B774-C05BBFA77AB1
P2860
The antitumor potential of Interleukin-27 in prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The antitumor potential of Interleukin-27 in prostate cancer.
@ast
The antitumor potential of Interleukin-27 in prostate cancer.
@en
The antitumor potential of Interleukin-27 in prostate cancer.
@nl
type
label
The antitumor potential of Interleukin-27 in prostate cancer.
@ast
The antitumor potential of Interleukin-27 in prostate cancer.
@en
The antitumor potential of Interleukin-27 in prostate cancer.
@nl
prefLabel
The antitumor potential of Interleukin-27 in prostate cancer.
@ast
The antitumor potential of Interleukin-27 in prostate cancer.
@en
The antitumor potential of Interleukin-27 in prostate cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
The antitumor potential of Interleukin-27 in prostate cancer.
@en
P2093
Carlo Sorrentino
Emanuela Ognio
Emma Di Carlo
Gabriella Mincione
Serena Di Meo
P2860
P304
10332-10341
P356
10.18632/ONCOTARGET.1425
P407
P577
2014-11-01T00:00:00Z